Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

7 structures for Q8IUC6

Entry ID Method Resolution Chain Position Source
2M1X NMR - A 387-545 PDB
2M63 NMR - A 1-156 PDB
3RC4 X-ray 150 A B 360-372 PDB
4BSX X-ray 223 A A/B/C/D 1-153 PDB
4C0M X-ray 280 A A/B/C/D 1-153 PDB
5JEL X-ray 160 A B 199-217 PDB
AF-Q8IUC6-F1 Predicted AlphaFoldDB

667 variants for Q8IUC6

Variant ID(s) Position Change Description Diseaes Association Provenance
CA9105442
RCV000707570
rs777499533
3 C>G Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV002554382
RCV001055148
rs142880589
CA9105437
13 D>N Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001204826
rs2093591434
22 K>R Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV000650573
CA9105424
rs79591246
32 T>I Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs758634091
RCV001351499
CA9105421
34 R>H Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA9105419
RCV001339969
rs765301499
41 D>G Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA9105418
rs375571285
RCV001247820
45 A>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA403493330
rs1437926927
RCV000698021
66 A>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
VAR_084055
rs372818181
CA9105402
RCV000808431
71 R>Q Herpes simplex encephalitis, susceptibility to, 4 no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs11466719
CA9105399
VAR_051416
RCV000650566
75 R>C Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA403493263
rs11466719
RCV001309886
75 R>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs935231020
RCV001047750
CA403493216
79 G>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001702542
CA9105395
VAR_084056
RCV000650558
rs199816697
80 V>M Herpes simplex encephalitis, susceptibility to, 4 no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001228817
rs2093590817
87 E>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV000558222
rs141687483
CA9105390
RCV002530217
90 P>Q Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs2093590771
RCV001240964
91 D>E Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
CA9105389
rs369953609
RCV001302149
98 R>C Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
VAR_084057
RCV000693219
RCV002532230
CA9105384
rs201291933
111 A>T Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs199683447
RCV000707447
CA9105377
116 V>M Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs143789239
RCV000705831
CA9105372
122 V>I Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001308604
rs373241772
CA9105371
123 R>C Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000693305
rs755557071
CA9105360
132 R>Q Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
COSM1394205
rs387907307
RCV000030823
CA130135
141 R>* Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 large_intestine [NCI-TCGA, ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA9105353
RCV000704121
rs753365777
145 G>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
CA403492647
rs1202936308
RCV000685374
148 I>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
CA403492639
rs1599143486
RCV000792698
149 A>G Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001221974
rs2093590230
149 A>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV001208242
CA403492624
rs1224448097
151 D>N Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001318605
CA9105349
rs767397394
156 R>W Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
VAR_084059
CA9105346
rs770166865
RCV000700411
157 T>M Herpes simplex encephalitis, susceptibility to, 4 no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
RCV000547869
CA9105344
rs145148929
160 S>F Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA9105341
RCV001046218
rs780257437
162 L>V Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
dbSNP
gnomAD
rs753273529
RCV001037831
CA9105336
172 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000650560
CA9105333
rs141394423
COSM567218
180 R>C lung Herpes simplex encephalitis, susceptibility to, 4 [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs940970222
CA304548420
RCV001039077
180 R>H Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs146550489
RCV000030824
CA130138
VAR_069082
186 S>L Herpes simplex encephalitis, susceptibility to, 4 IIAE6; no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002552641
CA9105325
RCV001354618
rs747441149
RCV001048367
189 S>T Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs754876060
CA9105314
RCV000650563
205 S>N Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001213185
CA9105307
rs775445910
222 R>H Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
dbSNP
gnomAD
RCV001318542
rs760097887
CA9105305
227 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000693075
rs141739488
CA9105302
233 D>H Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA9105301
RCV000802529
rs141739488
233 D>N Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA9105300
RCV000898844
rs200697470
234 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs201853120
CA9105295
RCV000802607
240 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002534384
CA9105292
rs370487475
RCV000700624
241 E>K Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001045012
rs2093589331
244 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs151272128
RCV001703204
RCV000550916
CA9105288
245 G>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1555730283
RCV000585896
CA403491727
250 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs370748549
RCV001068489
CA9105278
258 S>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA9105272
rs767551524
RCV001056200
271 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1032622935
CA304548101
RCV002537303
RCV000809118
276 P>S Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA9105245
RCV000703758
RCV002534417
rs763590950
312 Q>R Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA9105231
rs757786083
RCV001315746
332 T>M Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA9105223
rs773920190
RCV001041974
342 T>P Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001035453
rs2093588326
343 S>F Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
CA403491085
rs1176341029
RCV001209590
348 P>L Variant assessed as Somatic; 0.0 impact. Herpes simplex encephalitis, susceptibility to, 4 [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
NCI-TCGA
dbSNP
gnomAD
rs769618186
RCV001068789
CA9105219
350 P>Q Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000793916
CA9105216
rs772349684
352 T>P Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000979433
rs11466722
365 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs11466722
RCV000686317
366 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs11466722
RCV000884994
366 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV000961580
rs11466722
367 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV000456078
RCV001516628
rs11466722
367 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV001307871
CA304547751
rs1028603882
368 S>P Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA9105195
rs147816959
RCV000822399
377 T>N Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001316774
rs2093587726
385 S>P Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
CA304547677
rs867839844
RCV001220013
390 S>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV000813760
RCV003166327
COSM998772
CA9105181
rs751265594
406 E>K Herpes simplex encephalitis, susceptibility to, 4 endometrium Inborn genetic diseases [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs749950910
RCV001203037
CA9105178
408 I>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV003224460
RCV000768337
CA9105173
rs372838204
413 R>Q Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000650564
rs140568066
CA9105165
422 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001340941
rs749928559
CA403490357
424 G>R Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001347067
rs770034965
CA304547528
452 I>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000650561
COSM1229272
rs1555730200
CA403489827
463 R>H Herpes simplex encephalitis, susceptibility to, 4 large_intestine [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
Ensembl
dbSNP
rs780460725
RCV001294575
CA9105145
470 N>K Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
ClinGen
ExAC
gnomAD
rs763237315
RCV001055509
481 G>R Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs199751361
CA9105129
RCV001226353
485 C>Y Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA9105110
rs772590478
RCV000650559
519 I>N Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000966471
RCV001726395
CA9105107
rs150740529
521 A>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs2093586437
RCV001202156
522 R>G Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV001056306
rs373671679
CA9105096
543 E>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000817413
rs1284363590
CA403489163
544 Q>H Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
CA9105086
RCV003162981
RCV000650562
VAR_084065
rs143066432
557 D>N Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs139939816
RCV000932961
CA9105083
560 R>W Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs2093585998
RCV001350075
566 L>M Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV001529334
rs143679494
RCV000543404
CA9105081
568 A>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA9105080
RCV000706813
rs148925210
574 L>V Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs752768415
RCV001297301
584 M>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs199784356
RCV000650568
CA9105075
588 Q>P Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV003117596
rs74359855
RCV000807139
RCV003166262
CA9105074
592 G>R Susceptibility to severe COVID-19 Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA9105072
VAR_084066
RCV001309641
rs561021962
595 M>L Herpes simplex encephalitis, susceptibility to, 4 no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs150224968
RCV000915616
CA9105069
VAR_084067
598 G>W Herpes simplex encephalitis, susceptibility to, 4 no effect on IFNB induction [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs2093585623
RCV001203328
605 A>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs759573569
CA9105046
RCV002553381
RCV001059478
628 P>L Herpes simplex encephalitis, susceptibility to, 4 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000802786
CA9105047
rs3177471
628 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs749105540
CA9105044
RCV001044506
630 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001206639
CA9105041
rs747059000
634 H>Q Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001214734
rs945545750
640 T>I Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
rs762126373
RCV001071107
643 P>missing Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinVar
dbSNP
RCV001344707
CA9105025
rs762670581
656 P>R Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001321805
rs148396522
CA9105023
658 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001043228
CA403488447
rs1292695561
658 P>S Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001306744
rs536690750
CA9105009
674 P>L Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000704138
CA9104991
rs200326236
703 A>T Herpes simplex encephalitis, susceptibility to, 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA403493745
rs1242807777
2 A>G No ClinGen
TOPMed
rs1294992486
CA403493747
2 A>S No ClinGen
gnomAD
VAR_084053
CA9105441
rs114566317
4 T>I inhibition of IFNB induction [UniProt] No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1291078777
CA403493736
4 T>P No ClinGen
gnomAD
rs1164350572
CA403493726
5 G>V No ClinGen
TOPMed
gnomAD
rs762981932
CA9105438
11 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA403493678
rs1425438537
13 D>G No ClinGen
gnomAD
CA9105436
rs142880589
13 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105435
rs762230516
14 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA9105434
rs371293615
15 L>V No ClinGen
ESP
ExAC
TOPMed
rs1425299327
CA403493659
16 G>D No ClinGen
TOPMed
TCGA novel 16 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760351659
CA9105432
18 A>V No ClinGen
ExAC
gnomAD
rs1227222730
CA403493627
21 D>E No ClinGen
gnomAD
CA9105429
rs745319253
21 D>G No ClinGen
ExAC
gnomAD
rs1385573307
CA403493610
24 L>S No ClinGen
TOPMed
gnomAD
CA403493593
rs1304302691
26 L>R No ClinGen
gnomAD
rs1406783378
CA403493588
27 K>R No ClinGen
gnomAD
CA403493554
rs1168190614
32 T>A No ClinGen
TOPMed
gnomAD
CA9105423
rs747970296
33 P>L No ClinGen
ExAC
gnomAD
CA9105422
rs780201394
34 R>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 34 R>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403493536
rs1200082984
35 P>L No ClinGen
gnomAD
rs1382688616
CA403493539
35 P>S No ClinGen
TOPMed
rs1223292796
CA403493507
40 Q>K No ClinGen
TOPMed
gnomAD
rs1480783596
CA403493483
43 L>P No ClinGen
gnomAD
rs1253414113
CA403493476
44 H>L No ClinGen
gnomAD
rs1253414113
CA403493477
44 H>R No ClinGen
gnomAD
VAR_038789 46 M>I a breast cancer sample; somatic mutation [UniProt] No UniProt
rs1284410549
CA403493459
47 V>I No ClinGen
gnomAD
CA9105415
rs761078466
51 L>V No ClinGen
ExAC
gnomAD
CA403493425
rs1392144677
52 G>D No ClinGen
gnomAD
CA403493420
rs1301345260
53 Q>R No ClinGen
gnomAD
rs201782115
VAR_084054
CA9105413
60 S>C inhibition of IFNB induction [UniProt] No ClinGen
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1464309068
CA403493373
60 S>P No ClinGen
gnomAD
TCGA novel 63 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403493332
rs1437926927
66 A>D No ClinGen
TOPMed
gnomAD
CA403493335
rs1180521404
66 A>T No ClinGen
TOPMed
gnomAD
rs1198375169
CA403493328
67 D>N No ClinGen
TOPMed
gnomAD
rs1198375169
CA403493327
67 D>Y No ClinGen
TOPMed
gnomAD
rs769794539
CA9105408
68 A>E No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 68 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304548829
rs147427321
68 A>T No ClinGen
ESP
TOPMed
gnomAD
rs769794539
CA9105407
68 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1226772448
CA403493304
70 A>G No ClinGen
TOPMed
rs746146801
CA9105403
71 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA403493277
rs1599143710
73 V>A No ClinGen
Ensembl
rs1599143705
CA403493273
74 A>P No ClinGen
Ensembl
rs1395735409
CA403493269
74 A>V No ClinGen
gnomAD
CA403493259
rs1337206286
75 R>H No ClinGen
gnomAD
CA403493245
rs1157942336
76 Q>H No ClinGen
gnomAD
CA403493247
rs756698093
76 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs756698093
CA9105397
76 Q>P No ClinGen
ExAC
TOPMed
gnomAD
rs753040804
CA9105396
77 W>* No ClinGen
ExAC
gnomAD
rs935231020
CA304548784
79 G>R No ClinGen
TOPMed
gnomAD
CA9105394
rs759244065
80 V>G No ClinGen
ExAC
CA403493192
rs1599143675
81 D>G No ClinGen
Ensembl
CA403493180
rs1244091677
82 S>N No ClinGen
gnomAD
CA403493178
rs1244091677
82 S>T No ClinGen
gnomAD
rs1463838095
CA403493164
83 T>I No ClinGen
gnomAD
rs150500469
CA9105392
84 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403493146
rs1352933258
85 D>H No ClinGen
gnomAD
CA304548764
rs550899449
86 P>Q No ClinGen
Ensembl
rs762322733
CA9105391
87 E>K No ClinGen
ExAC
gnomAD
CA403493099
rs1383854983
88 E>D No ClinGen
gnomAD
CA403493094
rs1317469292
89 P>T No ClinGen
gnomAD
rs1317551968
CA403493061
92 V>A No ClinGen
gnomAD
rs1470467112
CA403493066
92 V>M No ClinGen
TOPMed
CA304548752
rs985177967
93 S>P No ClinGen
Ensembl
CA403493003
rs369953609
98 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105388
rs761804578
98 R>H No ClinGen
ExAC
gnomAD
rs1160989710
CA403492987
99 L>F No ClinGen
gnomAD
CA304548736
rs952501643
100 Y>* No ClinGen
Ensembl
rs992744195
CA304548734
102 L>R No ClinGen
TOPMed
CA304548728
rs777976835
104 A>T No ClinGen
Ensembl
rs1385414651
CA403492937
104 A>V No ClinGen
gnomAD
CA9105383
rs771204742
111 A>G No ClinGen
ExAC
gnomAD
CA304548708
rs771204742
111 A>V No ClinGen
ExAC
gnomAD
rs749264598
CA9105382
112 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs777909657
CA9105381
113 L>P No ClinGen
ExAC
TOPMed
gnomAD
CA403492870
rs1005476424
114 R>G No ClinGen
TOPMed
CA9105380
rs139070404
114 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA304548702
rs1005476424
114 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs200773818
CA403492866
115 D>H No ClinGen
ExAC
TOPMed
gnomAD
CA9105379
rs200773818
115 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs751977492
CA9105376
119 Q>E No ClinGen
ExAC
gnomAD
rs765891838
CA9105375
119 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA9105374
rs762671258
120 E>K No ClinGen
ExAC
gnomAD
rs901328850
CA304548677
121 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA9105370
rs768611254
123 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA9105369
rs768611254
123 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs760336209
CA9105368
124 T>I No ClinGen
ExAC
gnomAD
CA403492808
rs1199346881
125 L>F No ClinGen
gnomAD
rs775366110
CA9105367
125 L>H No ClinGen
ExAC
gnomAD
CA304548642
rs1009819273
126 S>R No ClinGen
TOPMed
rs1271210390
CA403492792
128 R>G No ClinGen
gnomAD
CA9105366
rs770987789
128 R>T No ClinGen
ExAC
gnomAD
CA403492786
rs1274012750
129 D>N No ClinGen
gnomAD
CA9105363
rs564906226
131 H>R No ClinGen
1000Genomes
ExAC
gnomAD
rs781746645
CA9105361
132 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA403492752
rs1407583940
134 G>E No ClinGen
gnomAD
CA304548610
rs999886809
135 E>D No ClinGen
Ensembl
CA403492747
rs1599143523
135 E>G No ClinGen
Ensembl
CA304548616
rs891500607
135 E>Q No ClinGen
TOPMed
gnomAD
CA9105358
rs751804319
137 Q>R No ClinGen
ExAC
gnomAD
rs1176319634
CA403492713
140 A>T No ClinGen
gnomAD
CA9105357
rs387907307
141 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA9105356
rs750138490
141 R>Q No ClinGen
ExAC
TOPMed
gnomAD
VAR_084058 141 R>del inhibition of IFNB induction [UniProt] No UniProt
CA403492688
rs761271093
143 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs761271093
CA9105354
143 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs764694460
CA9105355
143 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs753365777
CA403492673
145 G>E No ClinGen
ExAC
gnomAD
CA403492655
rs1261090209
147 D>G No ClinGen
TOPMed
gnomAD
rs1303872299
CA403492629
150 G>E No ClinGen
gnomAD
rs1371998685
CA403492605
153 G>E No ClinGen
TOPMed
gnomAD
rs775140912
CA403492607
CA9105350
153 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs376914657
CA9105348
156 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403492553
rs1408873493
159 Q>H No ClinGen
gnomAD
CA9105343
rs769041568
161 N>H No ClinGen
ExAC
gnomAD
CA9105342
rs747610140
161 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs780257437
CA403492537
162 L>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1461624013
CA403492493
168 S>C No ClinGen
gnomAD
rs1461624013
CA403492492
168 S>F No ClinGen
gnomAD
CA9105339
rs373468408
169 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA403492484
rs1284404080
170 A>T No ClinGen
gnomAD
CA403492481
rs1322959750
170 A>V No ClinGen
TOPMed
CA9105337
rs756911879
171 L>S No ClinGen
ExAC
gnomAD
CA403492471
rs1250357322
172 P>R No ClinGen
TOPMed
CA403492473
rs753273529
172 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA403492465
rs1480788600
173 S>C No ClinGen
TOPMed
rs763658275
CA9105335
175 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA403492429
rs1345844073
179 P>S No ClinGen
gnomAD
CA403492412
rs1164466818
182 I>T No ClinGen
gnomAD
rs375230364
CA9105332
182 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105329
rs765489270
184 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA9105328
rs765489270
184 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA9105327
rs762194513
185 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1356657375
CA403492351
191 G>V No ClinGen
gnomAD
CA304548381
rs866478664
191 G>W No ClinGen
Ensembl
CA403492348
rs1600054043
192 C>G No ClinGen
Ensembl
rs772478656
CA9105323
193 S>C No ClinGen
ExAC
gnomAD
rs746169578
CA403492332
195 R>* No ClinGen
ExAC
gnomAD
CA9105322
rs746169578
195 R>G No ClinGen
ExAC
gnomAD
rs779250040
CA9105321
195 R>Q No ClinGen
ExAC
gnomAD
rs756897138
CA9105320
197 T>A No ClinGen
ExAC
gnomAD
CA403492318
rs1403120145
198 G>S No ClinGen
gnomAD
CA403492307
rs1303978682
199 S>I No ClinGen
gnomAD
CA403492309
rs1303978682
199 S>N No ClinGen
gnomAD
CA9105318
rs562147335
199 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA403492303
rs1369946046
200 P>S No ClinGen
gnomAD
rs1265495063
CA403492299
201 A>T No ClinGen
gnomAD
CA403492284
rs1600054001
203 L>P No ClinGen
Ensembl
CA403492282
rs1427727215
204 A>T No ClinGen
gnomAD
rs766336167
CA9105312
209 I>N No ClinGen
ExAC
gnomAD
rs766336167
CA403492234
209 I>T No ClinGen
ExAC
gnomAD
rs1222745582
CA403492191
212 S>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA403492192
rs1222745582
212 S>Y No ClinGen
gnomAD
CA403492152
rs1227093064
215 M>I No ClinGen
gnomAD
rs764252931
CA9105309
219 S>R No ClinGen
ExAC
gnomAD
CA403492108
rs1484557050
219 S>R No ClinGen
TOPMed
rs1344952261
CA403492069
222 R>C No ClinGen
gnomAD
rs772559700
CA9105306
223 S>N No ClinGen
ExAC
gnomAD
rs895523368
CA304548301
224 P>S No ClinGen
TOPMed
CA403492028
rs1261195841
225 H>P No ClinGen
TOPMed
rs1281678153
CA403492034
225 H>Y No ClinGen
gnomAD
CA403492017
rs1297831092
226 G>E No ClinGen
gnomAD
CA403492022
rs1394540891
226 G>R No ClinGen
TOPMed
gnomAD
CA403492009
rs1461234309
227 P>S No ClinGen
gnomAD
CA9105304
rs774682259
228 S>R No ClinGen
ExAC
gnomAD
CA403491988
rs1173048927
229 K>Q No ClinGen
TOPMed
rs1427468517
CA403491971
230 L>I No ClinGen
TOPMed
rs903323285
CA304548274
233 D>A No ClinGen
Ensembl
CA403491901
rs1194878909
236 A>S No ClinGen
TOPMed
gnomAD
CA403491897
rs1194878909
236 A>T No ClinGen
TOPMed
gnomAD
rs780633461
CA9105298
237 S>G No ClinGen
ExAC
gnomAD
CA304548253
rs569449121
238 L>F No ClinGen
1000Genomes
CA9105297
rs150390826
238 L>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA403491827
rs1568365385
241 E>D No ClinGen
Ensembl
CA403491838
rs370487475
241 E>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403491821
rs1279859842
242 P>S No ClinGen
TOPMed
rs760807669
CA9105291
243 V>I No ClinGen
ExAC
gnomAD
CA403491793
rs151272128
245 G>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 245 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9105289
rs151272128
245 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA403491741
rs1195951951
249 E>G No ClinGen
TOPMed
rs771453047
CA9105286
249 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA9105287
rs771453047
249 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs763249230
CA9105285
250 P>S No ClinGen
ExAC
gnomAD
rs372593861
CA9105283
254 S>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372593861
CA9105282
254 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM1666362
CA9105281
rs370345154
256 P>L eye [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
gnomAD
rs939720063
CA304548180
257 P>L No ClinGen
gnomAD
rs370748549
CA304548176
258 S>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9105276
rs750164988
260 E>K No ClinGen
ExAC
gnomAD
CA403491618
rs1206192015
261 I>F No ClinGen
gnomAD
CA403491615
rs1361092940
261 I>T No ClinGen
TOPMed
CA9105275
rs778636825
262 A>T No ClinGen
ExAC
gnomAD
CA403491609
COSM1394202
rs1260265211
262 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1461196504
CA403491591
265 P>Q No ClinGen
gnomAD
rs1300806411
CA403491585
266 E>A No ClinGen
TOPMed
CA304548155
rs111760366
266 E>K No ClinGen
Ensembl
CA9105274
rs756342788
268 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1313222893
CA403491568
269 S>N No ClinGen
gnomAD
CA403491560
rs1261663079
270 S>N No ClinGen
gnomAD
CA9105273
rs752908663
271 P>S No ClinGen
ExAC
gnomAD
rs755005131
CA9105271
272 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA403491544
rs1397775692
273 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs11466721
CA304548107
VAR_051417
275 L>V No ClinGen
UniProt
Ensembl
dbSNP
rs766809661
CA9105269
276 P>L No ClinGen
ExAC
gnomAD
CA403491525
rs1444390257
277 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1244190978
CA403491505
280 P>T No ClinGen
TOPMed
gnomAD
CA403491498
rs1218883426
281 D>H No ClinGen
TOPMed
CA9105267
rs773613526
282 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs1600053776
CA403491485
283 T>P No ClinGen
Ensembl
CA9105265
rs546707391
287 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1355968207
CA403491453
288 P>L No ClinGen
gnomAD
CA403491455
rs1205741026
288 P>S No ClinGen
gnomAD
CA403491446
rs1248703865
289 D>E No ClinGen
TOPMed
rs776106254
CA9105264
289 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA403491447
rs1358449489
289 D>V No ClinGen
gnomAD
rs768443709
CA9105263
290 T>I No ClinGen
ExAC
gnomAD
rs1600053763
CA403491444
290 T>P No ClinGen
Ensembl
rs200901007
CA9105260
292 A>P No ClinGen
1000Genomes
ExAC
gnomAD
COSM1394201
rs200901007
CA9105259
292 A>T Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs1382231970
CA403491428
293 A>P No ClinGen
gnomAD
TCGA novel 295 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9105258
rs778743730
297 S>I No ClinGen
ExAC
gnomAD
rs778743730
CA403491400
297 S>N No ClinGen
ExAC
gnomAD
TCGA novel 298 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304548055
rs1012958701
298 T>S No ClinGen
TOPMed
CA403491393
rs1237024981
298 T>S No ClinGen
TOPMed
gnomAD
CA9105257
rs757039942
299 N>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 299 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304548048
rs550919185
300 Y>* No ClinGen
1000Genomes
rs1423658533
CA403491380
300 Y>C No ClinGen
gnomAD
rs749133560
CA403491373
301 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs749133560
CA9105256
301 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA403491377
rs1386215939
301 P>T No ClinGen
gnomAD
VAR_084060 302 V>L no effect on IFNB induction [UniProt] No UniProt
CA9105255
rs530685103
304 C>G No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 305 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766504909
CA9105253
306 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs766504909
CA9105252
306 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs758917743
CA9105251
307 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA9105250
rs750934698
308 S>F No ClinGen
ExAC
gnomAD
CA9105248
rs762032500
309 A>V No ClinGen
ExAC
gnomAD
rs958394435
CA304547992
310 G>A No ClinGen
Ensembl
rs1337207471
CA403491311
312 Q>* No ClinGen
gnomAD
rs377055358
CA304547980
313 S>A No ClinGen
ESP
TOPMed
rs771753171
CA9105243
313 S>F No ClinGen
ExAC
gnomAD
CA9105242
rs201474033
318 I>S No ClinGen
1000Genomes
ExAC
gnomAD
CA403491276
rs1403830160
318 I>V No ClinGen
gnomAD
CA9105241
rs373898244
319 L>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403491266
rs1334463581
320 E>Q No ClinGen
gnomAD
CA9105240
rs369756552
321 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369756552
CA403491255
321 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105238
rs777615352
322 V>A No ClinGen
ExAC
gnomAD
CA9105237
rs747280830
324 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA403491238
rs1600053637
324 N>T No ClinGen
Ensembl
CA403491230
rs1198738783
325 P>H No ClinGen
TOPMed
gnomAD
CA403491232
rs1198738783
325 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs780079114
CA9105235
325 P>S No ClinGen
ExAC
gnomAD
CA304547915
rs201243827
327 S>P No ClinGen
1000Genomes
CA9105233
rs750536106
330 D>A No ClinGen
ExAC
gnomAD
rs978559582
CA304547912
330 D>E No ClinGen
Ensembl
CA403491194
rs1384542664
331 Q>* No ClinGen
TOPMed
CA9105232
rs779228290
331 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs1409052982
CA403491182
333 P>S No ClinGen
TOPMed
CA9105227
rs752435609
337 S>P No ClinGen
ExAC
gnomAD
CA9105225
rs767227836
340 D>G No ClinGen
ExAC
rs1367704580
CA403491139
340 D>N No ClinGen
TOPMed
gnomAD
rs1367704580
CA403491137
340 D>Y No ClinGen
TOPMed
gnomAD
CA403491129
rs1401418673
341 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA9105222
rs770773137
344 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs1157605355
CA403491111
344 P>L No ClinGen
gnomAD
CA304547878
rs1019593923
346 T>A No ClinGen
gnomAD
CA403491102
rs1019593923
346 T>P No ClinGen
gnomAD
CA9105221
rs763009126
348 P>A No ClinGen
ExAC
gnomAD
CA403491089
rs763009126
348 P>S No ClinGen
ExAC
gnomAD
rs867468409
CA304547859
349 C>G No ClinGen
Ensembl
rs780203292
CA9105217
351 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA403491069
rs1568365240
351 P>S No ClinGen
Ensembl
rs1178964015
CA403491062
352 T>I No ClinGen
gnomAD
CA403491060
rs944010613
353 P>A No ClinGen
TOPMed
gnomAD
CA9105215
rs745867761
353 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA304547837
rs944010613
353 P>S No ClinGen
TOPMed
gnomAD
CA403491046
rs1241783574
355 T>I No ClinGen
gnomAD
rs1600053552
CA403491050
355 T>P No ClinGen
Ensembl
CA403491043
rs1312255598
356 P>L No ClinGen
gnomAD
CA9105214
rs779115581
356 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs757691551
CA9105212
358 T>I No ClinGen
ExAC
gnomAD
rs868138061
CA304547805
359 S>P No ClinGen
Ensembl
CA403491019
rs1349456859
360 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA9105210
rs778249228
361 P>H No ClinGen
ExAC
gnomAD
rs756503936
CA9105209
362 P>S No ClinGen
ExAC
gnomAD
rs1454029056
CA403490996
364 P>L No ClinGen
gnomAD
rs753132678
CA9105208
364 P>S No ClinGen
ExAC
gnomAD
rs767013628
CA9105207
365 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1360931234
CA403490995
365 P>T No ClinGen
gnomAD
CA403490986
rs1408916796
366 P>L No ClinGen
gnomAD
rs759303487
CA9105206
366 P>S No ClinGen
ExAC
gnomAD
TCGA novel 367 P>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403490975
rs1160690760
368 S>L No ClinGen
gnomAD
CA9105198
rs751024228
370 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1241108091
CA403490962
371 P>A No ClinGen
gnomAD
CA9105197
rs200885543
374 A>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 375 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762846466
CA9105196
376 L>Q No ClinGen
ExAC
TOPMed
gnomAD
CA9105194
rs147816959
VAR_084061
377 T>I no effect on IFNB induction [UniProt] No ClinGen
UniProt
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs371955184
CA304547725
380 S>A No ClinGen
ESP
TOPMed
CA9105193
rs761536693
381 L>Q No ClinGen
ExAC
gnomAD
VAR_084062 386 L>P no effect on IFNB induction [UniProt] No UniProt
CA304547691
rs925438567
387 E>V No ClinGen
TOPMed
CA9105190
rs375800474
388 S>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105191
rs375800474
388 S>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs778832857
CA9105189
390 S>T No ClinGen
ExAC
gnomAD
TCGA novel 392 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
VAR_084063 392 Q>K inhibition of IFNB induction [UniProt] No UniProt
rs1314836674
CA403490607
394 F>L No ClinGen
gnomAD
TCGA novel 396 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403490547
rs1193770166
398 V>E No ClinGen
TOPMed
rs778372322
CA9105186
399 I>V No ClinGen
ExAC
gnomAD
CA304547665
rs201821648
400 L>F No ClinGen
Ensembl
rs1568365190
CA403490528
400 L>H No ClinGen
Ensembl
rs781665133
CA9105183
402 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA304547649
rs781665133
402 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA304547650
rs781665133
402 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA403490500
rs1466893137
402 A>V No ClinGen
TOPMed
CA403490479
rs1174760913
404 A>G No ClinGen
TOPMed
CA9105182
rs754569139
404 A>T No ClinGen
ExAC
gnomAD
rs1162658317
CA403490451
407 H>L No ClinGen
gnomAD
CA403490442
rs1474785136
409 A>S No ClinGen
gnomAD
TCGA novel 409 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776276419
CA9105175
411 R>Q No ClinGen
ExAC
gnomAD
rs1222695665
CA403490424
412 V>A No ClinGen
gnomAD
rs763998229
CA9105174
412 V>I No ClinGen
ExAC
gnomAD
CA403490419
rs372838204
413 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105170
rs201008382
416 L>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9105171
rs201008382
416 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 417 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 418 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9105169
rs773495939
418 A>T No ClinGen
ExAC
gnomAD
rs770414344
CA9105168
418 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1294358833
CA403490374
421 V>L No ClinGen
gnomAD
rs1294358833
CA403490375
421 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA403490365
rs1287588056
422 P>L No ClinGen
TOPMed
rs758048210
CA9105162
423 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA9105161
rs749928559
424 G>W No ClinGen
ExAC
TOPMed
gnomAD
rs995707106
CA304547575
426 T>A No ClinGen
TOPMed
gnomAD
CA403490333
rs1191480606
426 T>I No ClinGen
gnomAD
rs995707106
CA403490342
426 T>P No ClinGen
TOPMed
gnomAD
rs143873813
CA304547573
429 E>* No ClinGen
ESP
TOPMed
gnomAD
CA9105158
rs753854196
429 E>D No ClinGen
ExAC
gnomAD
CA403490252
rs1204402796
432 Q>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs763968688
CA9105157
433 V>M No ClinGen
ExAC
gnomAD
rs1221705597
COSM1229273
CA403490220
434 P>L large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1260578950
CA403490225
434 P>S No ClinGen
gnomAD
rs1302225605
CA403490215
435 G>R No ClinGen
gnomAD
CA304547562
rs770119168
436 R>H No ClinGen
Ensembl
CA9105154
rs766706840
437 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs544182648
CA403490182
438 E>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1304258918
CA403490175
438 E>G No ClinGen
TOPMed
gnomAD
rs544182648
CA9105153
438 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1304258918
CA403490173
438 E>V No ClinGen
TOPMed
gnomAD
rs1456485558
CA403490148
440 S>N No ClinGen
TOPMed
rs1464927747
CA403490110
443 Q>* No ClinGen
gnomAD
CA403490080
rs1400867889
445 A>T No ClinGen
TOPMed
gnomAD
TCGA novel 447 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770034965
CA9105151
452 I>N No ClinGen
ExAC
TOPMed
gnomAD
CA9105150
rs748211950
453 I>V No ClinGen
ExAC
gnomAD
CA403489924
rs1600053207
457 T>P No ClinGen
Ensembl
CA9105148
rs769060173
459 N>S No ClinGen
ExAC
gnomAD
CA304547500
rs912607337
460 F>L No ClinGen
gnomAD
CA403489871
rs1458506074
461 D>N No ClinGen
gnomAD
CA403489850
rs1376015491
462 C>R No ClinGen
TOPMed
TCGA novel 462 C>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403489831
rs1600053170
463 R>C No ClinGen
Ensembl
TCGA novel 465 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
VAR_084064 465 S>N no effect on IFNB induction [UniProt] No UniProt
CA403489787
rs1600053156
467 H>P No ClinGen
Ensembl
rs747334545
CA9105146
467 H>Q No ClinGen
ExAC
gnomAD
TCGA novel 467 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1240501361
CA403489789
467 H>Y No ClinGen
gnomAD
CA304547477
rs986785530
469 V>M No ClinGen
Ensembl
CA9105144
rs771696411
472 A>T No ClinGen
ExAC
gnomAD
TCGA novel
CA9105143
rs201878837
473 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
CA9105142
rs374044969
474 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1256701940
CA403489695
474 M>T No ClinGen
gnomAD
CA304547459
rs756715938
476 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs1306575408
CA403489661
477 L>I No ClinGen
TOPMed
gnomAD
rs1306575408
CA403489659
477 L>V No ClinGen
TOPMed
gnomAD
CA403489638
rs1377448921
478 T>M No ClinGen
gnomAD
CA9105137
rs752524876
479 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA9105138
rs752524876
479 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA9105134
rs750634396
481 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA9105135
rs763237315
481 G>W No ClinGen
ExAC
gnomAD
CA9105132
rs761898820
483 P>S No ClinGen
ExAC
gnomAD
CA403489573
rs769204651
484 D>A No ClinGen
ExAC
gnomAD
CA9105130
rs769204651
484 D>V No ClinGen
ExAC
gnomAD
CA9105131
rs776581496
484 D>Y No ClinGen
ExAC
gnomAD
rs199751361
CA403489558
485 C>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1179770457
CA403489512
490 L>R No ClinGen
TOPMed
rs1600053068
CA403489483
495 S>P No ClinGen
Ensembl
rs1260358672
CA403489474
496 P>L No ClinGen
TOPMed
gnomAD
CA304547375
rs1052560323
496 P>S No ClinGen
TOPMed
CA403489439
rs746263278
502 D>H No ClinGen
ExAC
gnomAD
CA9105126
rs746263278
502 D>N No ClinGen
ExAC
gnomAD
CA403489427
rs1600053029
503 T>M No ClinGen
Ensembl
CA403489425
rs1600053016
504 A>P No ClinGen
Ensembl
CA9105118
rs754776028
510 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs1287750498
CA403489385
511 V>M No ClinGen
TOPMed
gnomAD
CA9105117
rs765491561
512 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs762011679
CA304547307
512 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs762011679
CA9105115
512 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA9105116
rs765491561
512 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA9105113
rs543684306
514 D>N No ClinGen
1000Genomes
ExAC
gnomAD
CA9105112
rs775931722
516 H>Q No ClinGen
ExAC
gnomAD
TCGA novel 518 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9105108
rs150740529
521 A>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs748943819
CA9105106
522 R>S No ClinGen
ExAC
gnomAD
TCGA novel 524 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403489285
rs1600052919
527 T>P No ClinGen
Ensembl
CA403489268
rs1257006852
529 K>T No ClinGen
TOPMed
CA304547271
rs1012551976
533 L>F No ClinGen
Ensembl
CA9105101
rs142171170
534 Q>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1168740338
CA403489235
534 Q>P No ClinGen
TOPMed
rs1400099215
CA403489226
535 A>G No ClinGen
gnomAD
rs1400099215
CA403489225
535 A>V No ClinGen
gnomAD
rs779772992
CA9105099
536 R>Q No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel
rs754043860
CA9105097
539 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
TOPMed
gnomAD
NCI-TCGA
rs377509189
CA304547251
539 M>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA9105098
rs376286418
539 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1460955056
CA403489191
541 R>G No ClinGen
gnomAD
TCGA novel 541 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403489179
rs1357331436
542 K>M No ClinGen
TOPMed
rs1600052827
CA403489169
544 Q>E No ClinGen
Ensembl
CA9105095
rs756098119
546 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA403489148
rs774037288
547 R>* No ClinGen
gnomAD
CA304547239
rs774037288
547 R>G No ClinGen
gnomAD
rs567288271
CA9105094
547 R>P No ClinGen
1000Genomes
ExAC
gnomAD
rs567288271
CA9105093
547 R>Q No ClinGen
1000Genomes
ExAC
gnomAD
CA403489134
rs1211446763
550 R>Q No ClinGen
gnomAD
CA9105091
COSM1394198
rs146110283
550 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA9105088
rs550630185
555 H>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769503444
CA9105087
556 L>M No ClinGen
ExAC
gnomAD
CA403489084
rs1435372660
557 D>V No ClinGen
gnomAD
CA9105084
rs768703212
558 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA403489067
rs1400135507
560 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA403489051
rs1172020591
562 Q>R No ClinGen
gnomAD
CA403489043
rs1427361110
563 A>E No ClinGen
TOPMed
gnomAD
CA403489047
rs1467248135
563 A>T No ClinGen
gnomAD
rs1427361110
CA403489042
563 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 564 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403489033
rs1478454282
565 A>S No ClinGen
TOPMed
gnomAD
CA304547185
rs143679494
568 A>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1237489267
CA403489002
570 Y>C No ClinGen
gnomAD
CA403489005
rs1456278955
570 Y>H No ClinGen
gnomAD
rs148925210
CA403488977
574 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9105079
rs777799844
575 Q>E No ClinGen
ExAC
gnomAD
CA9105078
rs146025102
580 Y>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA403488914
rs1432416352
583 Q>* No ClinGen
TOPMed
CA403488912
rs1238346584
583 Q>R No ClinGen
gnomAD
rs752768415
CA9105077
584 M>R No ClinGen
ExAC
gnomAD
rs767639735
CA9105076
586 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs1404572089
CA403488881
587 L>P No ClinGen
TOPMed
gnomAD
rs1404572089
CA403488880
587 L>R No ClinGen
TOPMed
gnomAD
CA9105071
rs773634335
595 M>K No ClinGen
ExAC
gnomAD
CA403488830
rs561021962
595 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA403488804
rs1459004660
599 T>A No ClinGen
gnomAD
rs1205209111
CA403488796
600 G>E No ClinGen
gnomAD
CA403488799
rs1600052634
600 G>R No ClinGen
Ensembl
CA403488789
rs760290741
601 A>E No ClinGen
ExAC
gnomAD
rs760290741
CA9105066
601 A>V No ClinGen
ExAC
gnomAD
rs772059316
CA9105064
602 P>T No ClinGen
ExAC
gnomAD
rs1285465360
CA403488781
603 Y>H No ClinGen
TOPMed
CA9105063
rs371157055
603 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1272431262
CA403488774
604 G>R No ClinGen
gnomAD
rs1196941925
COSM998771
CA403488761
606 R>* endometrium [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
rs1196941925
CA403488762
606 R>G No ClinGen
TOPMed
gnomAD
CA9105062
rs377447415
606 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 608 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1242792048
CA403488746
608 P>S No ClinGen
gnomAD
CA9105061
rs545638589
609 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9105059
rs781426719
611 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs748411534
CA403488729
611 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs748411534
CA9105060
611 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA403488726
rs781426719
611 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs1380324887
CA403488720
612 Q>L No ClinGen
TOPMed
TCGA novel 617 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs147826426
CA9105056
618 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201230476
CA9105054
619 P>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9105052
rs761523820
620 P>R No ClinGen
ExAC
gnomAD
CA9105053
rs765749722
620 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs113327885
CA9105050
623 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs760042063
CA9105049
625 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 627 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749105540
CA9105043
630 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1328721015
CA403488603
632 P>S No ClinGen
TOPMed
gnomAD
rs1276340415
CA403488589
634 H>R No ClinGen
gnomAD
rs780241594
CA9105039
635 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs750982483
CA9105037
638 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA304547024
rs945545750
640 T>S No ClinGen
Ensembl
rs939615253
CA304547019
641 P>S No ClinGen
TOPMed
CA403488542
rs779591355
642 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA9105035
rs757644032
642 P>R No ClinGen
ExAC
gnomAD
CA9105036
rs779591355
642 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs763771528
CA9105032
643 P>R No ClinGen
ExAC
gnomAD
rs371551573
CA9105033
643 P>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs762126373 643 P>T Variant assessed as Somatic; 6.352e-05 impact. [NCI-TCGA] No NCI-TCGA
rs1195467807
CA403488530
644 P>L No ClinGen
gnomAD
CA304546989
rs866241522
645 S>P No ClinGen
TOPMed
rs1487696328
CA403488527
645 S>Y No ClinGen
gnomAD
CA403488522
rs1265265917
646 P>A No ClinGen
gnomAD
CA403488519
rs1378371332
646 P>L No ClinGen
TOPMed
rs767102846
CA9105029
652 P>Q No ClinGen
ExAC
gnomAD
rs1256733631
CA403488475
653 Q>R No ClinGen
gnomAD
rs774225442
CA9105027
654 S>P No ClinGen
ExAC
TOPMed
gnomAD
CA9105026
rs766318423
656 P>T No ClinGen
ExAC
gnomAD
TCGA novel 657 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs148396522
CA9105024
658 P>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA403488433
rs772147268
660 S>F No ClinGen
ExAC
gnomAD
rs1168527684
CA403488434
660 S>P No ClinGen
gnomAD
CA9105020
rs772147268
660 S>Y No ClinGen
ExAC
gnomAD
rs1423777381
CA403488426
661 P>L No ClinGen
gnomAD
rs745954690
CA9105019
662 A>T No ClinGen
ExAC
gnomAD
CA9105017
rs779499603
665 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA403488403
rs779499603
665 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs1177683632
CA403488404
665 T>S No ClinGen
gnomAD
VAR_051418
rs11466724
CA304546946
666 A>T No ClinGen
UniProt
TOPMed
dbSNP
CA403488384
COSM1394196
rs1464382188
669 A>T large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
CA9105016
rs757840131
670 P>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA9105013
rs755698549
671 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA9105014
rs755698549
671 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1260123335
CA403488365
672 Q>R No ClinGen
gnomAD
rs1232325668
CA403488359
673 S>R No ClinGen
gnomAD
rs536690750
CA9105010
674 P>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1219577557
CA403488328
678 P>S No ClinGen
gnomAD
rs766300346
CA9105007
679 L>F No ClinGen
ExAC
gnomAD
CA9105006
rs749530535
680 I>M No ClinGen
ExAC
CA403488277
rs772973812
683 H>Q No ClinGen
ExAC
gnomAD
rs376421303
COSM1394195
CA9105002
684 A>T large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
TCGA novel 685 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1464116110
CA403488257
685 Q>R No ClinGen
gnomAD
rs1376651302
CA403488241
686 M>T No ClinGen
gnomAD
TCGA novel 687 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403488227
rs1176424540
687 V>L No ClinGen
gnomAD
CA403488202
rs1378908682
689 L>M No ClinGen
TOPMed
gnomAD
rs1178539097
CA403488183
690 G>E No ClinGen
gnomAD
rs775729703
CA9105000
692 N>H No ClinGen
ExAC
gnomAD
rs772195426
CA9104999
692 N>K No ClinGen
ExAC
gnomAD
rs745872856
CA9104998
694 H>N No ClinGen
ExAC
TOPMed
gnomAD
CA304546868
rs764426478
694 H>R No ClinGen
Ensembl
CA9104994
CA304546853
CA9104995
rs778249694
695 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA9104996
rs771550869
695 M>T No ClinGen
ExAC
gnomAD
CA9104997
rs774636609
695 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA403488031
rs1239184528
700 G>A No ClinGen
gnomAD
VAR_084068 702 Q>R no effect on IFNB induction [UniProt] No UniProt
rs1203336562
CA403487984
703 A>V No ClinGen
gnomAD
rs1303045695
CA403487979
704 P>S No ClinGen
gnomAD
CA9104989
rs751058834
705 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1476609338
CA403487885
710 E>K No ClinGen
TOPMed
rs758303498
CA9104987
711 A>T No ClinGen
ExAC
gnomAD

1 associated diseases with Q8IUC6

[MIM: 614850]: Encephalopathy, acute, infection-induced, 6, herpes-specific (IIAE6)

A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome. {ECO:0000269|PubMed:22105173}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

Without disease ID
  • A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome. {ECO:0000269|PubMed:22105173}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

3 regional properties for Q8IUC6

Type Name Position InterPro Accession
domain Toll/interleukin-1 receptor homology (TIR) domain 393 - 553 IPR000157
domain RHIM domain 677 - 697 IPR025735
domain TRIF, N-terminal 1 - 148 IPR040886

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasmic vesicle, autophagosome
  • Cytoplasm, cytosol
  • Mitochondrion
  • Colocalizes with UBQLN1 in the autophagosome (PubMed:21695056)
  • Colocalizes in the cytosol with DDX1, DDX21 and DHX36
  • Colocalizes in the mitochondria with DDX1 and poly(I:C) RNA ligand
  • The multi-helicase-TICAM1 complex may translocate to the mitochondria upon poly(I:C) RNA ligand stimulation (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
autophagosome A double-membrane-bounded compartment that engulfs endogenous cellular material as well as invading microorganisms to target them to the lytic vacuole/lysosome for degradation as part of macroautophagy.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
endosome membrane The lipid bilayer surrounding an endosome.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
ripoptosome A protein complex whose core components are the receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3 (also called RIP1 and RIP3). Formation of the ripoptosome can induce an extrinsic apoptotic signaling pathway or a necroptotic signaling pathway. The composition of this protein complex may depend on several factors including nature of the signal, cell type and more.

1 GO annotations of molecular function

Name Definition
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.

30 GO annotations of biological process

Name Definition
apoptotic signaling pathway The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
B cell proliferation The expansion of a B cell population by cell division. Follows B cell activation.
cellular response to lipopolysaccharide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
cellular response to oxidised low-density lipoprotein particle stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxidized lipoprotein particle stimulus.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
I-kappaB kinase/NF-kappaB signaling The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
inflammatory response The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
lipopolysaccharide-mediated signaling pathway The series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
macrophage activation involved in immune response A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
nitric oxide biosynthetic process The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.
positive regulation of autophagy Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
positive regulation of B cell proliferation Any process that activates or increases the rate or extent of B cell proliferation.
positive regulation of chemokine production Any process that activates or increases the frequency, rate, or extent of chemokine production.
positive regulation of cytokine production involved in inflammatory response Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of I-kappaB kinase/NF-kappaB signaling Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
positive regulation of interferon-beta production Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
positive regulation of interleukin-6 production Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
positive regulation of macrophage cytokine production Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
positive regulation of myeloid dendritic cell cytokine production Any process that activates or increases the frequency, rate, or extent of myeloid dendritic cell cytokine production.
positive regulation of natural killer cell activation Any process that activates or increases the frequency, rate or extent of natural killer cell activation.
positive regulation of NF-kappaB transcription factor activity Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
positive regulation of nitric oxide biosynthetic process Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
positive regulation of protein binding Any process that activates or increases the frequency, rate or extent of protein binding.
positive regulation of protein ubiquitination Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
positive regulation of tumor necrosis factor production Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production.
regulation of protein-containing complex assembly Any process that modulates the frequency, rate or extent of protein complex assembly.
response to exogenous dsRNA Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.
TRIF-dependent toll-like receptor signaling pathway The series of molecular signals initiated by a ligand binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MACTGPSLPS AFDILGAAGQ DKLLYLKHKL KTPRPGCQGQ DLLHAMVLLK LGQETEARIS
70 80 90 100 110 120
LEALKADAVA RLVARQWAGV DSTEDPEEPP DVSWAVARLY HLLAEEKLCP ASLRDVAYQE
130 140 150 160 170 180
AVRTLSSRDD HRLGELQDEA RNRCGWDIAG DPGSIRTLQS NLGCLPPSSA LPSGTRSLPR
190 200 210 220 230 240
PIDGVSDWSQ GCSLRSTGSP ASLASNLEIS QSPTMPFLSL HRSPHGPSKL CDDPQASLVP
250 260 270 280 290 300
EPVPGGCQEP EEMSWPPSGE IASPPELPSS PPPGLPEVAP DATSTGLPDT PAAPETSTNY
310 320 330 340 350 360
PVECTEGSAG PQSLPLPILE PVKNPCSVKD QTPLQLSVED TTSPNTKPCP PTPTTPETSP
370 380 390 400 410 420
PPPPPPPSST PCSAHLTPSS LFPSSLESSS EQKFYNFVIL HARADEHIAL RVREKLEALG
430 440 450 460 470 480
VPDGATFCED FQVPGRGELS CLQDAIDHSA FIILLLTSNF DCRLSLHQVN QAMMSNLTRQ
490 500 510 520 530 540
GSPDCVIPFL PLESSPAQLS SDTASLLSGL VRLDEHSQIF ARKVANTFKP HRLQARKAMW
550 560 570 580 590 600
RKEQDTRALR EQSQHLDGER MQAAALNAAY SAYLQSYLSY QAQMEQLQVA FGSHMSFGTG
610 620 630 640 650 660
APYGARMPFG GQVPLGAPPP FPTWPGCPQP PPLHAWQAGT PPPPSPQPAA FPQSLPFPQS
670 680 690 700 710
PAFPTASPAP PQSPGLQPLI IHHAQMVQLG LNNHMWNQRG SQAPEDKTQE AE